399 related articles for article (PubMed ID: 24040964)
21. Human fetal ventricular cardiomyocyte, RL-14 cell line, is a promising model to study drug metabolizing enzymes and their associated arachidonic acid metabolites.
Maayah ZH; Elshenawy OH; Althurwi HN; Abdelhamid G; El-Kadi AO
J Pharmacol Toxicol Methods; 2015; 71():33-41. PubMed ID: 25454080
[TBL] [Abstract][Full Text] [Related]
22. Regulation of forskolin-induced cAMP production by cytochrome P450 epoxygenase metabolites of arachidonic acid in HEK293 cells.
Abukhashim M; Wiebe GJ; Seubert JM
Cell Biol Toxicol; 2011 Oct; 27(5):321-32. PubMed ID: 21519968
[TBL] [Abstract][Full Text] [Related]
23. Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer.
Wei X; Zhang D; Dou X; Niu N; Huang W; Bai J; Zhang G
BMC Cancer; 2014 Nov; 14():841. PubMed ID: 25406731
[TBL] [Abstract][Full Text] [Related]
24. Role of cytochrome P450-mediated arachidonic acid metabolites in the pathogenesis of cardiac hypertrophy.
Alsaad AM; Zordoky BN; Tse MM; El-Kadi AO
Drug Metab Rev; 2013 May; 45(2):173-95. PubMed ID: 23600686
[TBL] [Abstract][Full Text] [Related]
25. Role of cytochrome P450-epoxygenase and soluble epoxide hydrolase in the regulation of vascular response.
Nayeem MA; Geldenhuys WJ; Hanif A
Adv Pharmacol; 2023; 97():37-131. PubMed ID: 37236764
[TBL] [Abstract][Full Text] [Related]
26. Cytochrome P450 epoxygenases 2C8 and 2C9 are implicated in hypoxia-induced endothelial cell migration and angiogenesis.
Michaelis UR; Fisslthaler B; Barbosa-Sicard E; Falck JR; Fleming I; Busse R
J Cell Sci; 2005 Dec; 118(Pt 23):5489-98. PubMed ID: 16291720
[TBL] [Abstract][Full Text] [Related]
27. CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice.
Chen G; Xu R; Zhang S; Wang Y; Wang P; Edin ML; Zeldin DC; Wang DW
Am J Physiol Endocrinol Metab; 2015 Jan; 308(2):E97-E110. PubMed ID: 25389366
[TBL] [Abstract][Full Text] [Related]
28. The factor in EDHF: Cytochrome P450 derived lipid mediators and vascular signaling.
Fleming I
Vascul Pharmacol; 2016 Nov; 86():31-40. PubMed ID: 26975734
[TBL] [Abstract][Full Text] [Related]
29. Emerging role of epoxyeicosatrienoic acids in coronary vascular function.
Larsen BT; Gutterman DD; Hatoum OA
Eur J Clin Invest; 2006 May; 36(5):293-300. PubMed ID: 16634832
[TBL] [Abstract][Full Text] [Related]
30. Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids.
Spiecker M; Liao JK
Arch Biochem Biophys; 2005 Jan; 433(2):413-20. PubMed ID: 15581597
[TBL] [Abstract][Full Text] [Related]
31. Differential effect of amyloid β on the cytochrome P450 epoxygenase activity in rat brain.
Sarkar P; Narayanan J; Harder DR
Neuroscience; 2011 Oct; 194():241-9. PubMed ID: 21843605
[TBL] [Abstract][Full Text] [Related]
32. Increased epoxyeicosatrienoic acids may be part of a protective mechanism in human ulcerative colitis, with increased CYP2J2 and reduced soluble epoxide hydrolase expression.
Qiu YE; Qin J; Luo Y; Qin SL; Mu YF; Cun R; Jiang HL; Chen JJ; Yu MH; Zhong M
Prostaglandins Other Lipid Mediat; 2018 May; 136():9-14. PubMed ID: 29580941
[TBL] [Abstract][Full Text] [Related]
33. Crosstalk between adenosine receptors and CYP450-derived oxylipins in the modulation of cardiovascular, including coronary reactive hyperemic response.
Nayeem MA; Hanif A; Geldenhuys WJ; Agba S
Pharmacol Ther; 2022 Dec; 240():108213. PubMed ID: 35597366
[TBL] [Abstract][Full Text] [Related]
34. The Role of Epoxyeicosatrienoic Acids in Cardiac Remodeling.
Lai J; Chen C
Front Physiol; 2021; 12():642470. PubMed ID: 33716791
[TBL] [Abstract][Full Text] [Related]
35. Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function.
Imig JD
Adv Pharmacol; 2016; 77():105-41. PubMed ID: 27451096
[TBL] [Abstract][Full Text] [Related]
36. Sexually Dimorphic Regulation of EET Synthesis and Metabolism: Roles of Estrogen.
Huang A; Sun D
Front Pharmacol; 2018; 9():1222. PubMed ID: 30420806
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease.
Theken KN; Schuck RN; Edin ML; Tran B; Ellis K; Bass A; Lih FB; Tomer KB; Poloyac SM; Wu MC; Hinderliter AL; Zeldin DC; Stouffer GA; Lee CR
Atherosclerosis; 2012 Jun; 222(2):530-6. PubMed ID: 22503544
[TBL] [Abstract][Full Text] [Related]
38. Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart.
Edin ML; Wang Z; Bradbury JA; Graves JP; Lih FB; DeGraff LM; Foley JF; Torphy R; Ronnekleiv OK; Tomer KB; Lee CR; Zeldin DC
FASEB J; 2011 Oct; 25(10):3436-47. PubMed ID: 21697548
[TBL] [Abstract][Full Text] [Related]
39. Biochemical characterization of the human liver cytochrome P450 arachidonic acid epoxygenase pathway.
Zeldin DC; Moomaw CR; Jesse N; Tomer KB; Beetham J; Hammock BD; Wu S
Arch Biochem Biophys; 1996 Jun; 330(1):87-96. PubMed ID: 8651708
[TBL] [Abstract][Full Text] [Related]
40. Cytochrome P450 epoxygenases as EDHF synthase(s).
Fleming I
Pharmacol Res; 2004 Jun; 49(6):525-33. PubMed ID: 15026030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]